ANNX Return on Tangible Equity | ANNEXON, INC.

ANNEXON, INC. (ANNX) Return on Tangible Equity

2026-06-30: Return Tang Equity -108.93%.
2026-03-31: Return Tang Equity -96.06%.
2025-12-31: Return Tang Equity -97.66%.
2025-09-30: Return Tang Equity -128.23%.

Complete source-backed return tang equity history.

Available history: 2019-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-108.93%
2026-03-31	-96.06%
2025-12-31	-97.66%
2025-09-30	-128.23%
2025-06-30	-93.92%
2025-03-31	-68.66%
2024-12-31	-47.15%
2024-09-30	-35.44%
2024-06-30	-31.89%
2024-03-31	-46.01%
2023-12-31	-53.58%
2023-09-30	-89.73%
2023-06-30	-77.58%
2023-03-31	-67.60%
2022-12-31	-61.40%
2022-09-30	-55.62%
2022-06-30	-86.57%
2022-03-31	-69.60%
2021-12-31	-56.20%
2021-09-30	-43.91%
2021-06-30	-32.57%
2021-03-31	-24.00%
2020-12-31	-18.42%
2020-09-30	-13.45%
2020-06-30	37.08%
2020-03-31	36.36%
2019-12-31	37.01%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-97.66%
2024-12-31	-47.15%
2023-12-31	-53.58%
2022-12-31	-61.40%
2021-12-31	-56.20%
2020-12-31	-18.42%
2019-12-31	37.01%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Corbus Pharmaceuticals Holdings, Inc. (CRBP)	United States	$0.144B	-1.72
SPRUCE BIOSCIENCES, INC. (SPRB)	United States	$0.142B	-2.89
Korro Bio, Inc. (KRRO)	United States	$0.141B	-1.81
Atrium Therapeutics, Inc. (RNA)	United States	$0.140B
Curanex Pharmaceuticals Inc (CURX)	United States	$0.138B
TuHURA Biosciences, Inc./NV (HURA)	United States	$0.134B	-4.88
Unicycive Therapeutics, Inc. (UNCY)	United States	$0.134B	-3.70
NRX Pharmaceuticals, Inc. (NRXP)	United States	$0.131B	-6.31
MEDICINOVA INC (MNOV)	United States	$0.130B	-6.04
LIFECORE BIOMEDICAL, INC. DE (LFCR)	United States	$0.163B	-8.50